Skip to main content

AstraZeneca starts manufacturing potential Oxford University vaccine and strikes deal with Bill Gates-backed health organizations

British drugmaker AstraZeneca has begun production of Oxford University’s potential coronavirus vaccine and doubled its manufacturing capacity to two billion doses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.